Dachaigh › Aillse colorectal › Oklahoma › Oklahoma City
Sgrùdaidhean clionaigeach Aillse colorectal ann an Oklahoma City, OK
Tha 22 sgrùdaidhean airson Aillse colorectal a’ lorg phàirtichean aig làraichean ann agus timcheall air Oklahoma City (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
The Vanguard Study: Testing a New Way to Screen for Cancer
A’ fastadhFàilte do shaor-thoilich fhallain
- University of Oklahoma Health Sciences Center, Oklahoma City
Family Communications After Genetic Testing
A’ fastadhFàilte do shaor-thoilich fhallain
- Mercy Hospital Oklahoma City, Oklahoma City
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
A’ fastadhÌre 1/2
- University of Oklahoma, Oklahoma City
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Mercy Hospital Oklahoma City, Oklahoma City
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
A’ fastadhÌre 1
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
A’ fastadhÌre 1
- University of Oklahoma Health Sciences Center, Oklahoma City
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
A’ fastadhÌre 1/2
- Stephenson Cancer Center, Oklahoma City
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
A’ fastadhÌre 1/2
- University of Oklahoma, Oklahoma City
Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer
A’ fastadhÌre 1
- University of Oklahoma Health Sciences Center, Oklahoma City
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
A’ fastadhÌre 3
- Clinical Study Site, Oklahoma City
A Study of DM002 in Patients With Advanced Solid Tumors
A’ fastadhÌre 1/2
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
A’ fastadhÌre 1/2
- University of Oklahoma Health Sciences Center, Oklahoma City
Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma
A’ fastadh
- TSET Health Promotion Research Center, Oklahoma City
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1/2
- Stephenson Cancer Center, Oklahoma City
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
A’ fastadhÌre 1/2
- SSM OKC Hightower Clinical, Oklahoma City
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
A’ fastadhÌre 2
- Hightower Clinical, Oklahoma City
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
A’ fastadhSgrùdadh amharc
- Mercy Hospital - OKC, Oklahoma City
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
A’ fastadhÌre 1
- OU Stephenson Cancer Center, Oklahoma City
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
A’ fastadhÌre 1
- OU Health Stephenson Cancer Center, Oklahoma City
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
A’ fastadhÌre 3Fàilte do shaor-thoilich fhallain
- Mercy Hospital Oklahoma City, Oklahoma City
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
A’ fastadhSgrùdadh amharc
- Mercy Hospital Oklahoma City, Oklahoma City
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
A’ fastadhSgrùdadh amharc
- Mercy Clinic Oncology and Hematology - Coletta, Oklahoma City
Sgrùdaidhean Aillse colorectal ann am bailtean eile
- Houston, TX102 sgrùdaidhean
- New York City, NY78 sgrùdaidhean
- Nashville, TN69 sgrùdaidhean
- Boston, MA63 sgrùdaidhean
- Los Angeles, CA59 sgrùdaidhean
- Arlington, VA52 sgrùdaidhean
- St. Louis, MO50 sgrùdaidhean
- San Antonio, TX46 sgrùdaidhean
- Philadelphia, PA44 sgrùdaidhean
- Grand Rapids, MI40 sgrùdaidhean
- Baldwin Park, CA37 sgrùdaidhean
- Chicago, IL34 sgrùdaidhean
Sgrùdaidhean eile ann an Oklahoma City
- Aillse Sgamhain Neo-chealla-beag28 sgrùdaidhean
- Cancer Ovarian28 sgrùdaidhean
- Ailse Endometrial25 sgrùdaidhean
- Aillse Prostata21 sgrùdaidhean
- Ailseachadh nan Sgamhan19 sgrùdaidhean
- Aillse a' bhroilleach17 sgrùdaidhean
- Ailse metastatach16 sgrùdaidhean
- Aillse (gach seòrsa)14 sgrùdaidhean
- Leukemia myeloid geur14 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil13 sgrùdaidhean
- Aillse sa bhlaire11 sgrùdadh
- Cancer Pancreatic11 sgrùdadh
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.